January 5, 2022
Several UNC School of Medicine and UNC Health faculty and staff are authors of publications in a special edition of the North Carolina Medical Journal's first issue for the new year. These authors include Crystal W. Cené, MD, MPH, Randi J. Towns, Megan Canady, MSW, MSPH, Molly Berkoff, MD, MPH, and Andrea Bozoki, MD.
January 4, 2022
Cosmos, a website dedicated to the science of everything, posted a top ten list of the best science videos of 2021, and coming in at number seven is a video of cellular movement from research in the labs of Klaus Hahn and Tim Elson, both in the UNC Department of Pharmacology.
January 3, 2022
James F. Howard Jr., MD, professor in the UNC Department of Neurology, was principal investigator of the phase 3 trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.
December 29, 2021
Kim Shoenbill, MD, PhD, at UNC Family Medicine and colleagues published the study "An Analysis of Inpatient Tobacco Use Treatment Transition to Telehealth" in Nicotine & Tobacco Research. The study provides the first analysis of inpatient tobacco use treatment during the transition to telehealth during the COVID-19 pandemic. It finds that telehealth services for inpatient populations resulted in a larger scope of patients reached and expanded participation in cessation counseling.
December 23, 2021
Jenny Ting, PhD, is the recipient of the Illinois State University Distinguished Alumni Award for her outstanding immunology research.
December 21, 2021
UNC is part of a national effort, funded by the National Institutes of Health (NIH) Diversity Program Consortium, to identify best mentoring practices for scientists underrepresented in biomedical research.
December 15, 2021
Scientists at UNC-Chapel Hill led by Bryan L. Roth, MD, PhD, and colleagues from the University of Southern California and Northeastern University, have created and validated V-SYNTHES – a computational method to quickly screen billions of theoretical compounds for researchers to explore as potential therapies. Their work was published in Nature.
December 15, 2021
The UNC School of Medicine is accepting applications for the second round of Bridge Funding for Fiscal Year 2022. The deadline for applications is January 17, 2022.
December 15, 2021
The Eshelman Institute for Innovation recently opened its pre-proposal application for the 2022 annual grant cycle. The Institute seeks to fund translational research related to therapeutics focused on oncology, infectious disease, and neuroscience, including rare diseases, and all digital health technologies. The Institute also welcomes ideas for devices and diagnostics, and other therapeutic areas and services.
December 14, 2021
Four research teams at the UNC School of Medicine won $25,000 pilot grants with the goal of increasing collaborations throughout the neurosciences, as part of a UNC NeuroSpark event.
December 14, 2021
The Coronavirus Variant Sequencing (CORVASEQ) Surveillance Program, led by a team of UNC researchers, has detected the Omicron SARS-CoV-2 variant in North Carolina. Together, members of the program at UNC-Chapel Hill, UNC-Charlotte, Duke, Wake Forest, and East Carolina have sequenced more than 10,000 samples from COVID-19 positive patients to track the spread and development of the virus across the state.
December 7, 2021
TraCS Team Science is seeking to assist UNC researchers with the formation and development of multidisciplinary research teams focused on tackling challenging problems in clinical or translational medicine through the new ACTeR program. Support is provided through a combination of competitively reviewed graduated direct funding and logistical support.